We are live on ! Find out more
REVBU

Revelation Biosciences, Inc. Unit
REVBU

Delisted

REVBU was delisted on the 11th of January, 2023.

Back to rankings

3 hedge funds and large institutions have $51K invested in Revelation Biosciences, Inc. Unit in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 4 → 3 (-1)

100% less capital invested

Capital invested by funds: $11.1M → $51K (-$11.1M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
-$11M
2
WAM
Wolverine Asset Management
Illinois
-$79.8K
3
UBS Group
UBS Group
Switzerland
-$1.06K
Name Holding Trade Value Shares
Change 		Change in
Stake
CFN
1
Cordasco Financial Network
Florida
$49K – – –
UBS Group
2
UBS Group
Switzerland
$2K -$1.06K -100 -37%
GCL
3
Glazer Capital LLC
New York
– -$11M -1,035,652 Closed
WAM
4
Wolverine Asset Management
Illinois
– -$79.8K -7,510 -99%

REVBU Hedge Fund Activity: Q3 2021 in Review

3 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences, Inc. Unit (REVBU) for Q3 2021, worth a combined $51K — down 100% from $11.1M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of REVBU and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.

The largest seller was Glazer Capital LLC, exiting entirely with an estimated $11M sold.

  • 3 institutional investors held Revelation Biosciences, Inc. Unit (REVBU) as of Q3 2021, down from 4 in Q2 2021.
  • Funds reported $51K of Revelation Biosciences, Inc. Unit stock for Q3 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Revelation Biosciences, Inc. Unit positions in Q3 2021 and 1 closed out, a net change of -1 holder.
  • The largest Revelation Biosciences, Inc. Unit seller in Q3 2021 was Glazer Capital LLC, an estimated $11M sold.

Based on aggregated 13F filings for Q3 2021.